Statistical Learning for Epilepsy

TJ
Overseen ByTaylor J Abel, MD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how the brain processes speech, focusing on the supratemporal plane, which plays a role in hearing and understanding sounds. By using special monitoring methods during necessary medical procedures (sEEG), researchers aim to learn how the brain adapts to different speech sounds and listening situations through Dimension-Based Statistical Learning. The study seeks English-speaking individuals aged 15-25 who are already undergoing sEEG for epilepsy or language mapping and have normal hearing. As an unphased trial, it offers participants the chance to contribute to groundbreaking research on brain function and speech processing.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this protocol is safe for patients undergoing sEEG?

Research has shown that Dimension-Based Statistical Learning, particularly when combined with machine learning for epilepsy, is generally safe. For example, studies using similar machine learning methods to detect epileptic seizures have not revealed major safety issues. These studies primarily focus on model effectiveness rather than negative effects on patients.

This study also employs sEEG, a method already used in hospitals to monitor brain activity, indicating its safety in regular medical practice. Although specific safety data for Dimension-Based Statistical Learning in humans might not be detailed, the absence of reported problems in similar studies suggests confidence in its safety.12345

Why are researchers excited about this trial?

Researchers are excited about the Dimension-Based Statistical Learning technique for epilepsy because it offers a fresh approach to understanding and managing seizures. Unlike traditional treatments that focus on medication or surgical interventions, this method uses advanced data analysis to interpret brain signals, potentially identifying unique patterns associated with seizure activity. By leveraging statistical learning, this technique could lead to more personalized and effective management strategies for epilepsy, offering hope for patients who haven't responded well to existing treatments.

What evidence suggests that Dimension-Based Statistical Learning might be an effective treatment for epilepsy?

Research shows that Dimension-Based Statistical Learning, which participants in this trial will experience, can enhance understanding and prediction of seizures. Studies have found that analyzing various aspects of EEG tests, which measure brain activity, provides a good estimate of seizure risk. Advanced computer techniques, such as CNN-SVM and DNN-SVM models, have successfully identified epilepsy with high accuracy. One study demonstrated that using EEG signals predicted seizures with over 99% reliability. These findings suggest that this approach could effectively aid in understanding and managing epilepsy.46789

Who Is on the Research Team?

TJ

Taylor J Abel, MD

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for individuals aged 15-25 with epilepsy who are undergoing sEEG in the supratemporal plane and have normal hearing, vision, cognitive, and speech-language skills. They must be fluent English speakers without a history of autism or ADHD.

Inclusion Criteria

You have normal or corrected-to-normal vision.
My hearing is normal in both ears.
I am between 15 and 25 years old.
See 4 more

Exclusion Criteria

You do not speak or understand English well.
You have serious problems with understanding language or hearing.
You have been diagnosed with autism or ADHD in the past.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

sEEG-EEG Recording

Neural activity is measured via simultaneous EEG-sEEG monitoring in the supratemporal plane and other cortical regions as participants listen to acoustic stimuli with manipulated acoustic dimensions and in different listening contexts.

Up to 3 hours per session
1 session

Behavioral Response Collection

Behavioral responses are collected as participants provide category judgments based on perceived phonemes during acoustic stimuli presentation.

Up to 3 hours per session
1 session

Follow-up

Participants are monitored for any adverse effects or changes in neural response post-recording sessions.

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Dimension-Based Statistical Learning
Trial Overview The study explores how the brain processes speech by examining responses to voice onset time (VOT) and fundamental frequency (F0) during routine clinical sEEG monitoring in patients with epilepsy.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Patient ParticipantsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Carnegie Mellon University

Collaborator

Trials
80
Recruited
540,000+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+

Published Research Related to This Trial

A machine learning model using multi-modality features from 103 children with tuberous sclerosis complex (TSC) achieved a strong predictive accuracy (AUC of 0.812) for epilepsy drug treatment outcomes, highlighting the potential of advanced analytics in clinical settings.
Key factors influencing treatment outcomes included specific EEG characteristics, age of onset, and MRI lesion types, indicating that detailed clinical and imaging data can significantly inform treatment strategies for epilepsy in TSC patients.
Machine learning and statistic analysis to predict drug treatment outcome in pediatric epilepsy patients with tuberous sclerosis complex.Zhao, X., Jiang, D., Hu, Z., et al.[2023]
The study introduces new methods to reduce high-dimensional recordings of epileptic activity into low-dimensional (2D or 3D) representations, making it easier to visualize and analyze seizure prediction data.
Clustering algorithms were evaluated to automatically identify patterns within these low-dimensional descriptors, and the methods were adapted to effectively handle long-term datasets that can span several days or weeks.
Uncovering low-dimensional structure in high-dimensional representations of long-term recordings in people with epilepsy.Rapela, J., Proix, T., Todorov, D., et al.[2021]
The improved manifold adaptive Farahmand-Szepesvári-Audibert (FSA) dimension estimator provides a more accurate measure of intrinsic dimensionality in data analysis, outperforming previous methods like the mode and mean.
Using the corrected median-FSA estimator, researchers were able to identify brain areas with lower-dimensional dynamics that may be causal sources for epileptic seizures, highlighting its potential application in understanding neural dynamics during seizures.
Manifold-adaptive dimension estimation revisited.Benkő, Z., Stippinger, M., Rehus, R., et al.[2022]

Citations

EEG signal dimension is an index of seizure propensity ...Dimension provided a statistically robust (inverse) estimate of seizure susceptibility of mice, including mice with low seizure frequency or no ...
EEG-based epilepsy detection using CNN-SVM and DNN ...This study focuses on epilepsy detection using hybrid CNN-SVM and DNN-SVM models, combined with feature dimensionality reduction through PCA.
Novel seizure detection algorithm based on multi- ...The result shows that the AC, SP and seizure-based SE were 99.36%, 82.98% and 99.41% respectively. In order to solve the problem of unbalanced seizure data ...
On the performance of seizure prediction machine learning ...This study presents a patient-specific seizure prediction algorithm applied to diverse databases (EPILEPSIAE, CHB-MIT, AES, and Epilepsy Ecosystem).
Deep learning‐based seizure prediction using EEG signals ...In this study, we present a method for predicting epileptic seizures using electroencephalogram (EEG) signals.
Epileptic Seizure Detection Using Machine LearningThis meta-analysis reviews the performance of ML models in seizure detection and analyzes factors such as the model type (deep learning vs. traditional ML), ...
Entropy-driven deep learning framework for epilepsy ...This paper introduces a novel approach for the automatic identification of epilepsy in EEG signals by incorporating advanced entropy-based measures with modern ...
Epileptic seizure detection from electroencephalogram ...A review paper has examined various state-of-the-art machine-learning techniques for predicting seizures using EEG signals. To enhance the ...
(PDF) Interpretable Machine Learning for Epileptic Seizure ...This study aims to identify seizures in four different stages among epileptic patients, utilizing the Bangalore Epilepsy Dataset (BEED). This ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security